Active Ingredient History
Cefoxitin is a cephamycin antibiotic often grouped with the second-generation cephalosporins. It is active against a broad range of gram-negative bacteria including anaerobes. The methoxy group in the 7a position provides cefoxitin with a high degree of stability in the presence of beta-lactamases, both penicillinases and cephalosporinases, of gram-negative bacteria. The bactericidal action of cefoxitin results from inhibition of cell wall synthesis. NCATS
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Peritonitis (approved 2010)
Respiratory Tract Infections (approved 2010)
Urinary Tract Infections (approved 2010)
Antibiotic Prophylaxis (Phase 3)
Cesarean Section (Phase 2)
Colorectal Surgery (Phase 3)
Endometritis (Phase 2)
General Surgery (Phase 4)
Lung Diseases (Phase 2/Phase 3)
Pancreatic Diseases (Phase 3)
Pancreatic Neoplasms (Phase 3)
Urinary Tract Infections (Phase 4)
Wound Infection (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue